Key result
Takotsubo cardiomyopathy is linked to ~1-point lower in-hospital mortality compared to other ACS.
Why the study?
Takotsubo cardiomyopathy is an established differential diagnosis of MINOCA with significant clinical interest, but data on prognostication remain limited.
Does Takotsubo cardiomyopathy affect in-hospital mortality rates compared to other forms of acute coronary syndrome in adult patients?
Cohort (n=7,219,004)
Yes
Does Takotsubo cardiomyopathy affect in-hospital mortality rates compared to other forms of acute coronary syndrome in adult patients?
Absolute Event Rate: 7% vs 8.4%
p-value: p=<0.001
Takotsubo cardiomyopathy represents 1.0% of ACS admissions and carries a significant in-hospital mortality rate of 7.0%, for which an internally validated risk score may help clinicians stratify patient severity.
Substantial in-hospital mortality in Takotsubo cardiomyopathy merits vigilance; extends ACS differential data but leaves open prospective validation of risk scores.
BACKGROUND: Takotsubo cardiomyopathy (TC) is an established differential diagnosis of myocardial infarction with non-obstructive coronaries with significant interest but limited data on prognostication. We reviewed the characteristics and in-hospital outcomes and developed a novel risk score for TC. METHODS: Using the National Inpatient Sample data from 2016 to 2020, we identified adult patients (≥18 years) with acute coronary syndrome (ACS) and TC. We divided the cohort into ACS with and without TC and retrieved baseline data. Multivariable regression analysis was conducted to identify factors associated with TC diagnosis and adverse outcomes, leading to the development of a risk-scoring system. RESULTS: Among 7 219 004 adult ACS admissions, 78 214 (1.0%) were diagnosed with TC, with a mean age of 68.2 years, 64 526 (82.5%) being female and 5475 (7.0%, compared with 8.4% for other ACS) in-hospital mortality events. Factors significantly associated with TC were female sex (OR 6.78 (95% CI 6.47 to 7.09), p<0.001) and chronic heart failure (OR 1.60 (95% CI 1.54 to 1.66), p<0.001). A novel risk score was developed, including the following parameters: male sex, age >70 years, non-white race, hypertension, hyperlipidemia, history of coronary artery bypass grafting, history of percutaneous coronary intervention, cardiac arrhythmias, renal failure, cardiogenic shock and vasopressor use. The area under curves for in-hospital mortality was 0.716 in the derivation and 0.725 in the validation cohorts. CONCLUSIONS: TC remains a high-risk diagnosis in a minority of ACS cases, with mortality rates similar to other ACS causes. Our novel risk score offers a valuable tool for risk stratification in patients with TC, but external validation is needed to confirm its utility.
No takes yet. Share an insight, caveat, or question.
Agrawal et al. (2024) conducted a cohort in Acute coronary syndrome (ACS) (n=7,219,004). Takotsubo cardiomyopathy vs. Acute coronary syndrome without Takotsubo cardiomyopathy was evaluated on All-cause in-hospital mortality (p=<0.001). In-hospital all-cause mortality occurred in 7.0% of patients with Takotsubo cardiomyopathy compared to 8.4% of patients with other acute coronary syndromes (p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: